8-142912224-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000498.3(CYP11B2):​c.1399-131G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.607 in 1,486,664 control chromosomes in the GnomAD database, including 280,522 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.69 ( 37415 hom., cov: 30)
Exomes 𝑓: 0.60 ( 243107 hom. )

Consequence

CYP11B2
NM_000498.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.435

Publications

8 publications found
Variant links:
Genes affected
CYP11B2 (HGNC:2592): (cytochrome P450 family 11 subfamily B member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane. The enzyme has steroid 18-hydroxylase activity to synthesize aldosterone and 18-oxocortisol as well as steroid 11 beta-hydroxylase activity. Mutations in this gene cause corticosterone methyl oxidase deficiency. [provided by RefSeq, Jul 2008]
GML (HGNC:4375): (glycosylphosphatidylinositol anchored molecule like) Predicted to be involved in DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; apoptotic process; and negative regulation of cell population proliferation. Predicted to be extrinsic component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.881 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP11B2NM_000498.3 linkc.1399-131G>A intron_variant Intron 8 of 8 ENST00000323110.2 NP_000489.3 P19099

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP11B2ENST00000323110.2 linkc.1399-131G>A intron_variant Intron 8 of 8 1 NM_000498.3 ENSP00000325822.2 P19099
GMLENST00000522728.5 linkc.182-1739C>T intron_variant Intron 3 of 4 3 ENSP00000430799.1 E5RI31

Frequencies

GnomAD3 genomes
AF:
0.687
AC:
104268
AN:
151666
Hom.:
37358
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.889
Gnomad AMI
AF:
0.560
Gnomad AMR
AF:
0.675
Gnomad ASJ
AF:
0.652
Gnomad EAS
AF:
0.842
Gnomad SAS
AF:
0.743
Gnomad FIN
AF:
0.611
Gnomad MID
AF:
0.699
Gnomad NFE
AF:
0.568
Gnomad OTH
AF:
0.694
GnomAD4 exome
AF:
0.598
AC:
797666
AN:
1334880
Hom.:
243107
AF XY:
0.601
AC XY:
397707
AN XY:
661688
show subpopulations
African (AFR)
AF:
0.903
AC:
27814
AN:
30818
American (AMR)
AF:
0.666
AC:
23738
AN:
35644
Ashkenazi Jewish (ASJ)
AF:
0.655
AC:
16079
AN:
24554
East Asian (EAS)
AF:
0.845
AC:
30352
AN:
35932
South Asian (SAS)
AF:
0.742
AC:
57725
AN:
77820
European-Finnish (FIN)
AF:
0.622
AC:
25509
AN:
41016
Middle Eastern (MID)
AF:
0.699
AC:
3446
AN:
4932
European-Non Finnish (NFE)
AF:
0.562
AC:
577656
AN:
1028080
Other (OTH)
AF:
0.630
AC:
35347
AN:
56084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
16033
32066
48099
64132
80165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16242
32484
48726
64968
81210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.688
AC:
104386
AN:
151784
Hom.:
37415
Cov.:
30
AF XY:
0.694
AC XY:
51443
AN XY:
74146
show subpopulations
African (AFR)
AF:
0.889
AC:
36776
AN:
41378
American (AMR)
AF:
0.675
AC:
10316
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.652
AC:
2264
AN:
3472
East Asian (EAS)
AF:
0.841
AC:
4316
AN:
5130
South Asian (SAS)
AF:
0.744
AC:
3582
AN:
4812
European-Finnish (FIN)
AF:
0.611
AC:
6435
AN:
10536
Middle Eastern (MID)
AF:
0.704
AC:
207
AN:
294
European-Non Finnish (NFE)
AF:
0.568
AC:
38525
AN:
67862
Other (OTH)
AF:
0.690
AC:
1454
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1517
3034
4552
6069
7586
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
798
1596
2394
3192
3990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.606
Hom.:
36148
Bravo
AF:
0.697
Asia WGS
AF:
0.740
AC:
2574
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.53
DANN
Benign
0.27
PhyloP100
-0.43
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6433; hg19: chr8-143993640; API